Search research articles
Contact Us
Filters
Showing results (241-250 of 264) with videos related to
Page
of 27
Sort By:
International Journal of Clinical and Health Psychology : IJCHP
|
September 4, 2023
The impact of COVID-19 and socioeconomic status on psychological distress in cancer patients
Elisabeth Lucia Zeilinger, Matthias Knefel, Carmen Schneckenreiter, et al.
The Journal of Pathology
|
July 7, 2017
Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma
Sarah Moody, Leire Escudero-Ibarz, Ming Wang, et al.
Anticancer Research
|
February 7, 2016
A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours
Nicola Fazio, Roberto Buzzoni, Eric Baudin, et al.
Cancer Cell
|
April 16, 2022
Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron
Maximilian J Mair, Manfred Mitterer, Pia Gattinger, et al.
ESMO Open
|
October 14, 2020
Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field
Maximilian Marhold, Thais Topakian, Hermine Agis, et al.
Oncotarget
|
March 9, 2019
Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology
Gerald W Prager, Matthias Unseld, Fredrik Waneck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2014
Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients
Marius E Mayerhoefer, Georgios Karanikas, Kurt Kletter, et al.
Transplantation and Cellular Therapy
|
April 19, 2026
Austrian real-world experience with standard of care brexucabtagene autoleucel in patients with relapsed or refractory mantle-cell lymphoma
Stefan Koeck, Natalia Rotter, Olga Stiefel, et al.
Endocrine-Related Cancer
|
January 22, 2021
Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms
James C Yao, Jonathan Strosberg, Nicola Fazio, et al.
Neuroendocrinology
|
May 30, 2017
Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary
Simron Singh, Carlo Carnaghi, Roberto Buzzoni, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 264) with videos related to
Sort By:
Page
of 27
International Journal of Clinical and Health Psychology : IJCHP
|
September 4, 2023
The impact of COVID-19 and socioeconomic status on psychological distress in cancer patients
Elisabeth Lucia Zeilinger, Matthias Knefel, Carmen Schneckenreiter, et al.
The Journal of Pathology
|
July 7, 2017
Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma
Sarah Moody, Leire Escudero-Ibarz, Ming Wang, et al.
Anticancer Research
|
February 7, 2016
A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours
Nicola Fazio, Roberto Buzzoni, Eric Baudin, et al.
Cancer Cell
|
April 16, 2022
Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron
Maximilian J Mair, Manfred Mitterer, Pia Gattinger, et al.
ESMO Open
|
October 14, 2020
Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field
Maximilian Marhold, Thais Topakian, Hermine Agis, et al.
Oncotarget
|
March 9, 2019
Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology
Gerald W Prager, Matthias Unseld, Fredrik Waneck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2014
Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients
Marius E Mayerhoefer, Georgios Karanikas, Kurt Kletter, et al.
Transplantation and Cellular Therapy
|
April 19, 2026
Austrian real-world experience with standard of care brexucabtagene autoleucel in patients with relapsed or refractory mantle-cell lymphoma
Stefan Koeck, Natalia Rotter, Olga Stiefel, et al.
Endocrine-Related Cancer
|
January 22, 2021
Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms
James C Yao, Jonathan Strosberg, Nicola Fazio, et al.
Neuroendocrinology
|
May 30, 2017
Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary
Simron Singh, Carlo Carnaghi, Roberto Buzzoni, et al.
Page
of 27